Search results

Proposals at the Australian Centre for Neutron Scattering and National Deuteration Facility.

Using the Australian Synchrotron, an international team of researchers has characterised an important interaction that helps the SARS-CoV-2 virus invade human cells.

The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.

ANSTO works in partnerships and collaborative ventures with national and international organisations. Partner with ANSTO.

ANSTO physicist will gain further experience in particle therapy technologies.

Lutetium-177 used for advanced prostate cancer

The independent nuclear regulator, ARPANSA, is currently accepting submissions about ANSTO’s planned $59.8 million Intermediate Level Solid Waste Storage Facility.

ANSTO is interested finding students to collaborate on Generation IV reactor systems.

Over the last decades, neutron, photon, and ion beams have been established as an innovative and attractive investigative approach to characterise cultural-heritage materials.

The Biological Small Angle X-ray Scattering beamline will be optimised for measuring small angle scattering of surfactants, nanoparticles, polymers, lipids, proteins and other biological macromolecules in solution. BioSAXS combines combine a state-of-the-art high-flux small angle scattering beamline with specialised in-line protein purification and preparation techniques for high-throughput protein analysis.

Cracking the code for crop nutrition and food quality with X-ray fluorescence microscopy.

In Part 2 of our series exploring the world of nuclear science and technology at ANSTO, we share more detailed information about the nuclear scientist’s toolkit.

Accelerator technique used in pioneering biomaterials research led by the University of Sydney.

Winners of the Big Ideas Competition 2021

ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.